Evidence map›Paper›PMID 40902004›Full record

ArticleNucleic acids research2025

Structural basis for ligand recognition in the tobramycin riboswitch.

Elke Duchardt-Ferner, Leon Kraus, Anahita Limouchi, Beatrix Suess, Jens Wöhnert

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elke Duchardt-FernerInstitute for Molecular Biosciences and Center of Magnetic Resonance (BMRZ), Goethe-University Frankfurt, Max-von-Laue Straße 9, 60438 Frankfurt, Germany.ORCID 0000-0001-7521-8264
Leon KrausDepartment of Biology, Synthetic RNA Biology, TU Darmstadt, Schnittspahnstrasse 10, 64287 Darmstadt, Germany.
Anahita LimouchiInstitute for Molecular Biosciences and Center of Magnetic Resonance (BMRZ), Goethe-University Frankfurt, Max-von-Laue Straße 9, 60438 Frankfurt, Germany.
Beatrix SuessDepartment of Biology, Synthetic RNA Biology, TU Darmstadt, Schnittspahnstrasse 10, 64287 Darmstadt, Germany.ORCID 0000-0001-8666-6716
Jens WöhnertInstitute for Molecular Biosciences and Center of Magnetic Resonance (BMRZ), Goethe-University Frankfurt, Max-von-Laue Straße 9, 60438 Frankfurt, Germany.ORCID 0000-0001-7193-401X

Funding

Biomolecular Magnetic Resonance (BMRZ)Deutsche ForschungsgemeinschaftDFG INST161/816-1
6 · The paper itself

Abstract

Recently, a novel tobramycin-responsive riboswitch was developed by a combination of Capture-SELEX and in vivo screening. This riboswitch regulates translation initiation in eukaryotes with a high dynamic range and remarkable ligand affinity and selectivity. Its secondary structure differs from all previously described aminoglycoside-binding RNA motifs, suggesting a novel mode of ligand recognition. To provide a structural basis for the remarkable regulatory efficiency and ligand selectivity of this riboswitch, we investigated its structure in complex with its cognate ligand tobramycin by high-resolution solution nuclear magnetic resonance spectroscopy. The structure of the complex reveals a novel structural organization for an aminoglycoside binding motif with a unique pattern of intermolecular hydrogen bonds and electrostatic interactions between the RNA and functional groups of all three rings of the ligand. In contrast to other aminoglycoside binding motifs, ligand binding of the tobramycin riboswitch is coupled with the formation of an extensive network of noncanonical RNA-RNA interactions, rationalizing the high ligand affinity of this small hairpin RNA. Comparison with the free form of the RNA shows that the latter is much less compact, lacking many RNA-RNA interactions, in particular in the bulge regions, thereby immediately providing a rationale for the exceptional switching efficiency of this synthetic riboswitch.

Indexed as

Anti-Bacterial AgentsRiboswitchTobramycinBinding SitesHydrogen BondingLigandsModels, MolecularNucleic Acid ConformationAnti-Bacterial AgentsLigandsRiboswitchTobramycin

Identifiers

PMID40902004
PMCPMC12407100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.